Healthy volunteers test new heart Drug's absorption
NCT ID NCT07272330
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how the body absorbs a new drug called HRS-1893, which is being developed for heart muscle disease (cardiomyopathy). 38 healthy adults took different versions of the tablet, with and without food, to see which form works best and if food changes how much drug gets into the blood. The goal was to gather information for future studies, not to treat any disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Anzhen Hospital, Capital Medical University
Beijing, Beijing Municipality, 100029, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Implanted sensors may foresee heart failure crises
- Can a Gene-Silencing drug tame a rare heart disease?
- AI-Powered heart scans aim to predict deadly complications in muscular dystrophy
- New MRI scan could spot heart problems earlier
- New scan spots hidden heart disease in gene carriers before symptoms start
- Could your genes predict heart damage from irregular heartbeat?